Three-dimensional quantitative muscle ultrasound in patients with facioscapulohumeral dystrophy and myotonic dystrophy

被引:4
|
作者
de Jong, Leon [1 ]
Greco, Anna [2 ]
Nikolaev, Anton [1 ]
Weijers, Gert [1 ]
van Engelen, Baziel G. M. [2 ]
de Korte, Chris L. L. [1 ]
Futterer, Jurgen J. J. [1 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Dept Med Imaging, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Neurol, Nijmegen, Netherlands
基金
欧盟地平线“2020”;
关键词
diagnostic criteria; FSHD; muscle ultrasound; myotonic dystrophy; quantitative ultrasound; three-dimensional ultrasound;
D O I
10.1002/mus.27943
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction/AimsUltrasound imaging of muscle tissue conventionally results in two-dimensional sampling of tissue. For heterogeneously affected muscles, a sampling error using two-dimensional (2D) ultrasound can therefore be expected. In this study, we aimed to quantify and extend ultrasound imaging findings in neuromuscular disorders by using three-dimensional quantitative muscle ultrasound (3D QMUS). MethodsPatients with facioscapulohumeral dystrophy (n = 31) and myotonic dystrophy type 1 (n = 16) were included in this study. After physical examination, including Medical Research Council (MRC) scores, the tibialis anterior muscle was scanned with automated ultrasound. QMUS parameters were calculated over 15 cm of the length of the tibialis anterior muscle and were compared with a healthy reference data set. ResultsWith 3D QMUS local deviations from the healthy reference could be detected. Significant Pearson correlations (P < .01) between MRC score and QMUS parameters in male patients (n = 23) included the mean echo intensity (EI) (0.684), the standard deviation of EI (0.737), and the residual attenuation (0.841). In 91% of all patients, mean EI deviated by more than 1 standard deviation from the healthy reference. In general, the proportion of muscle tissue with a Z score >1 was about 50%. DiscussionIn addition to mean EI, multiple QMUS parameters reported in this study are potential biomarkers for pathology. Besides a moderate correlation of mean EI with muscle weakness, two other parameters showed strong correlations: standard deviation of EI and residual attenuation. Local detection of abnormalities makes 3D QMUS a promising method that can be used in research and potentially for clinical evaluation.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 50 条
  • [41] Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy
    Giorgio Tasca
    Mauro Monforte
    Maddalena Corbi
    Giuseppe Granata
    Donatella Lucchetti
    Alessandro Sgambato
    Enzo Ricci
    Molecular Neurobiology, 2018, 55 : 2959 - 2966
  • [42] Skeletal muscle sarcoplasmic reticulum phenotype in myotonic dystrophy
    Damiani, E
    Angelini, C
    Pelosi, M
    Sacchetto, R
    Bortoloso, E
    Margreth, A
    NEUROMUSCULAR DISORDERS, 1996, 6 (01) : 33 - 47
  • [43] Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy
    Tasca, Giorgio
    Monforte, Mauro
    Corbi, Maddalena
    Granata, Giuseppe
    Lucchetti, Donatella
    Sgambato, Alessandro
    Ricci, Enzo
    MOLECULAR NEUROBIOLOGY, 2018, 55 (04) : 2959 - 2966
  • [44] SKELETAL-MUSCLE BIOENERGETICS IN MYOTONIC-DYSTROPHY
    TAYLOR, DJ
    KEMP, GJ
    WOODS, CG
    EDWARDS, JH
    RADDA, GK
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 116 (02) : 193 - 200
  • [45] IN VIVO ASSESSMENT OF MUSCLE MEMBRANE PROPERTIES IN MYOTONIC DYSTROPHY
    Tan, S. Veronica
    Z'Graggen, Werner J.
    Boerio, Delphine
    Turner, Christopher
    Hanna, Michael G.
    Bostock, Hugh
    MUSCLE & NERVE, 2016, 54 (02) : 249 - 257
  • [46] Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy
    Nunes, Andreia M.
    Ramirez, Monique M.
    Garcia-Collazo, Enrique
    Jones, Takako Iida
    Jones, Peter L.
    HUMAN MOLECULAR GENETICS, 2024, 33 (10) : 872 - 883
  • [47] MSCS ARE KEY PLAYERS IN MUSCLE FIBROSIS DEVELOPMENT IN FACIOSCAPULOHUMERAL DYSTROPHY
    Serbina, O.
    Kiseleva, E.
    Vassetzky, Y.
    CYTOTHERAPY, 2021, 23 (05) : S53 - S54
  • [48] Contractile properties of single muscle fibers in myotonic dystrophy
    Krivickas, LS
    Ansved, T
    Suh, D
    Frontera, WR
    MUSCLE & NERVE, 2000, 23 (04) : 529 - 537
  • [49] Myotonic dystrophy: RNA-mediated muscle disease
    Wheeler, Thurman M.
    Thornton, Charles A.
    CURRENT OPINION IN NEUROLOGY, 2007, 20 (05) : 572 - 576
  • [50] Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients
    Nadaj-Pakleza, A.
    Lusakowska, A.
    Sulek-Piatkowska, A.
    Krysa, W.
    Rajkiewicz, M.
    Kwiecinski, H.
    Kaminska, A.
    FOLIA MORPHOLOGICA, 2011, 70 (02) : 121 - 129